LeMaitre Vascular, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LMAT research report →
About the company
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi.
- CEO
- George W. LeMaitre
- IPO
- 2006
- Employees
- 651
- HQ
- Burlington, MA, US
Price Chart
- Market Cap
- $2.35B
- P/E
- 37.28
- P/S
- 9.17
- P/B
- 5.77
- EV/EBITDA
- 26.10
- Div Yield
- 0.87%
- Gross Margin
- 72.39%
- Op Margin
- 28.51%
- Net Margin
- 24.35%
- ROE
- 16.19%
- ROIC
- 9.43%
- Revenue
- $249.60M · 13.53%
- Net Income
- $57.73M · 31.10%
- EPS
- $2.55 · 30.10%
- Op Income
- $67.91M
- FCF YoY
- 100.39%
- 52W High
- $118.01
- 52W Low
- $79.01
- 50D MA
- $99.63
- 200D MA
- $94.32
- Beta
- 0.52
- Avg Volume
- 286.32K
Get TickerSpark's AI analysis on LMAT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Jasinski Lawrence J | other | 0.466 |
| Jun 4, 26 | Jasinski Lawrence J | other | 0.558 |
| Jun 4, 26 | Jasinski Lawrence J | other | 0.86 |
| Jun 4, 26 | Jasinski Lawrence J | other | 0.76 |
| Jun 4, 26 | Jasinski Lawrence J | other | 1.427 |
| Jun 4, 26 | O'Connor John James | other | 0.466 |
| Jun 4, 26 | O'Connor John James | other | 0.558 |
| Jun 4, 26 | O'Connor John James | other | 0.86 |
| Jun 4, 26 | O'Connor John James | other | 0.76 |
| Jun 4, 26 | O'Connor John James | other | 1.427 |
Our LMAT coverage
Recent articles, reports, and earnings notes.
No research on LMAT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LMAT report →Similar companies
Peers in the same neighborhood.